The unassuming vial of eye drops could easily belong on a pharmacy shelf. But swirling inside are microscopic bits of photosynthetic machinery made out of plants. Inside minutes of giving the drops to mice, their eyes gain a unprecedented ability beyond that of any mammal. Like a leaf, they will now harness the facility of sunlight.
Photosynthetic eyes sound like they’re straight out of science fiction, but there’s a practical use researchers are after. Chemical reactions during photosynthesis generate powerful antioxidants that ward off inflammation and will potentially treat a variety of health conditions.
Called LEAF, the technology is creative, effective, and easy. Its essential ingredient might be present in food market spinach. In a paper detailing the work, researchers on the National University of Singapore and collaborators say they developed a mild chemical cocktail to extract among the core mechanisms utilized in photosynthesis.
Introduced to mammalian cells—including those who make up the cornea and immune cells—the floating photosynthetic particles made themselves at home and restarted work as usual when exposed to light. In mice with dry eye disease, LEAF repeatedly pumped out protective antioxidants, healed corneal scarring, and kept their eyes hydrated for days.
The animals scurried around as usual, with none inkling their eyes were now part plant.
“That is an exciting finding as we now have, for the primary time, demonstrated that plant photosynthetic machinery might be transplanted into mammalian tissue to generate biologically useful molecules, powered entirely by the identical light that allows our vision,” study writer Kuoran Xing on the National University of Singapore said in a press release. “We, too, can have limited photosynthetic abilities.”
Planting an Idea
Dry eye disease is one probably the most common eye problems, affecting roughly 1.5 billion people worldwide. Symptoms are hardly trivial. Irritation and chronic pain make day by day life miserable. Extra time, the disease causes scarring of the cornea, blurred vision, and sensitivity to light. The condition has been linked to depression, anxiety, and other health struggles.
Current treatments address the underlying inflammation, but they’re expensive, have limited availability, and long-term use can provoke uncomfortable unwanted side effects throughout the body.
At the center of the disease is a vicious, runaway cycle of cellular dysfunction. When our cells generate energy, in addition they produce byproducts called reactive oxygen species. Like tiny bullets, these wreak havoc if left unchecked. Some tunnel through delicate protective membranes and disrupt protein function. Others damage DNA, and in severe cases, cause cell death.
Our bodies always mop them up with a molecule called NADPH. But during inflammation the defenses are overwhelmed. Reactive oxygen species destroy the cells’ ability to make NADPH. Left unchecked, the cell enters a death spiral: It tries to keep up its supply of energy, but this satirically, generates more bullets and these activate immune cells. Attempting to boost NADPH under these conditions is a losing battle.
That’s why spinach caught the team’s attention. Plants make NADPH during photosynthesis. Powered by sunlight, they churn out energy and the antioxidant in completely other ways than our cells. Theoretically, adding plant-based machinery into our cells could bypass existing cellular mayhem and supply a brand new source of NADPH.
A plant-animal crossover sounds preposterous, however it already occurs in nature. The sacoglossan sea slug eats microalgae high in chloroplasts—the photosynthetic organelle in plant cells—and stores them intact in its guts. When it could possibly’t find food, the slug can survive on photosynthesis.
In previous studies inspired by the slug, scientists have tried transplanting core bits of photosynthetic machinery called thylakoids into animal cells. They give the impression of being like stacks of coins, but their interior structure is way more complex—any misalignment leads to catastrophic failure.
Researchers had already tried transplanting bits of this machinery into mouse knee cells but found it required high levels of a further chemical to maintain it in working order. In one other study, a team targeted rheumatoid arthritis, an inflammatory disease of the joints. But getting light into the tissues was a struggle, and the system needed lengthy exposure.
Eyes, nevertheless, are a natural window to visible light.
Eyes on the Prize
In the brand new study, the team’s essential invention was determining learn how to keep thylakoids intact while stripping away other parts of the chloroplast that destroy NADPH.
They eventually learned learn how to extract thylakoid particles from spinach in such a way as to maximise NADPH production. Measuring roughly 400 nanometers across—the scale of a really small bacteria—the particles produce NADPH when exposed to ambient light.
The team tested them on two kinds of cells answerable for dry eye disease: Large immune cells called macrophages and corneal cells. In petri dishes, each cell types readily soaked up LEAF. Once released contained in the cell, the plant thylakoids steadily pumped out NADPH.
Inside half-hour of sunshine exposure, the quantity of reactive oxygen species tanked. Indignant macrophages relaxed right into a state that battles inflammation. In tears collected from patients with dry eye disease, LEAF boosted NADPH levels roughly 20-fold and slashed a harmful oxidative chemical over 95 percent. Tests examining the broader metabolic landscape showed cells reverted to a healthier state after being treated with LEAF.
This photosynthesized NADPH supply can “power antioxidant metabolism,” promote cell repair, restore balance, and break the vicious cycle, wrote the team.
In a final test, they treated a mouse model of dry eye disease with the drops twice day by day for five days and pitted it against an approved chemical treatment. LEAF easily entered the animal’s eyes after half-hour. Under ambient light, the system doubled the quantity of NADPH and reversed corneal damage, outperforming the therapeutic drug.
Surprisingly, although the treatment is product of plant matter, it didn’t trigger immune attacks within the eyes or other parts of the body, resembling the liver or heart. However the team didn’t specifically test to see if the drops improved the animals’ eyesight or if adding the photosynthetic machinery modified their perception.
That said, LEAF is particularly well-suited for clinical use. It’s easily manufactured and stored and was consistently effective across 4 independent batches made in Singapore and China, with each sourced from local spinach. The nanoparticles are stable for 2 weeks at room temperature and last as long as a yr at -80 degrees Celsius.
Because LEAF “is derived from spinach, delivered as an easy eye drop, [and it] requires no external device or power source…we imagine it has a robust potential for clinical translation,” said study writer David Tai Leong.
Beyond dry eye disease, LEAF could possibly be made right into a cream that harnesses sunlight to treat skin inflammation disorders. The team can also be trying to generate photosynthetic molecules in deeper organs and boost the health of mitochondria, the cell’s energy factories.
“It is sort of surreal when considering of a possible future reality where human cells can have some limited but useful type of photosynthetic ability not only in the attention but elsewhere, too,” said Leong.